Related Experiment Video
Updated: Aug 19, 2026

06:54
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
Management of newly diagnosed metastatic carcinoma of the prostate
The Urologic Clinics of North America
|May 1, 1984
Abstract:
Metastatic prostatic cancer can be present in a variety of different ways. The authors describe the differences among stages D-0, D-1, and D-2 disease and present the treatment options for each of the substages. They summarize and integrate the clinical evidence that bears on the potential efficacy of each treatment.

